Prognostic value of BRAF/MIR-17 signature and B-Raf protein expression in patients with colorectal cancer: A pilot study.
Afaf T IbrahiemManal S FawzyBaraah T Abu AlSelEman Ali ToraihPublished in: Journal of clinical laboratory analysis (2020)
BRAF/MIR17 ratio could have prognostic utility in patients with CRC. Further larger-scale studies are warranted to confirm this utility.